Showing results (21-30 of 62) with videos related to

Sort By:
Pageof 7
Scientific Reports|January 12, 2021
Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasisLai Fun Thean, Christopher Blöcker, Hui Hua Li, et al.
BMC Cancer|October 9, 2025
Distinct genomic subgroups and mutational patterns in undifferentiated/dedifferentiated endometrial carcinomaChen-Yang Huang, Angel Chao, Chiao-Yun Lin, et al.
Breast Cancer Research : BCR|March 24, 2018
Functional genomics identifies specific vulnerabilities in PTEN-deficient breast cancerYew Chung Tang, Szu-Chi Ho, Elisabeth Tan, et al.
Genome Research|April 11, 2018
In-depth characterization of the cisplatin mutational signature in human cell lines and in esophageal and liver tumorsArnoud Boot, Mi Ni Huang, Alvin W T Ng, et al.
NPJ Genomic Medicine|December 22, 2017
Inherited breast cancer predisposition in Asians: multigene panel testing outcomes from SingaporeEdward S Y Wong, Sandhya Shekar, Marie Met-Domestici, et al.
Molecular Cell|May 30, 2017
Nucleus-Translocated ACSS2 Promotes Gene Transcription for Lysosomal Biogenesis and AutophagyXinjian Li, Willie Yu, Xu Qian, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 25, 2015
Abundant copy-number loss of CYCLOPS and STOP genes in gastric adenocarcinomaIoana Cutcutache, Alice Yingting Wu, Yuka Suzuki, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2013
Extensive diversity in circadian regulation of plasma lipids and evidence for different circadian metabolic phenotypes in humansEric Chern-Pin Chua, Guanghou Shui, Ivan Tian-Guang Lee, et al.
BMC Cancer|November 15, 2024
Molecular profiling reveals novel therapeutic targets and clonal evolution in ovarian clear cell carcinomaAngel Chao, Chen-Yang Huang, Willie Yu, et al.
Cancer Letters|June 19, 2017
A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancerYee Syuen Low, Christopher Blöcker, John R McPherson, et al.
Pageof 7